Related Experiment Videos
Sites on FIP-3 (NEMO/IKKgamma) essential for its phosphorylation and NF-kappaB modulating activity
1Department of Microbiology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, USA.
Abstract:
FIP-3 (NEMO/IKKgamma) is an essential modulator of the activity of NF-kappaB by mechanisms that include alterations in the phosphorylation, ubiquination, and degradation of IkappaBalpha. The multiple protein-protein interactions of FIP-3 (NEMO/IKKgamma) in a high molecular weight IKK complex indicated that this protein may be a link between some of the receptor-proximal upstream signal transduction molecules such as RIP and the downstream effects on IkappaBalpha. Although FIP-3 (NEMO/IKKgamma) has no intrinsic kinase activity, it has been shown to increase the kinase activity of IKKbeta. In this manuscript, the results of serine to alanine mutations at five sites on FIP-3 (NEMO/IKKgamma) are described, and functional assays demonstrated that two of these mutants affect both the phosphorylation and kinase activity of IKKbeta. Protein kinase Calpha appeared to be the kinase that was required for the posttranslational modification of FIP-3 (NEMO/IKKgamma). One of the serine targets of the protein kinase Calpha enzyme at amino acid 141 was within a leucine zipper-like sequence of FIP-3 (NEMO/IKKgamma), which might affect its interactions with other proteins on the signal transduction pathway. The second serine, which augmented the inhibition, was at amino acid 85 within the FIP-3 (NEMO/IKKgamma) interaction site with IKKbeta. When both serines were mutated simultaneously, the effect on IKKbeta and IkappaBalpha phosphorylation was more profoundly affected.
Insights
FIP-3 (NEMO/IKKgamma) modulates NF-kappaB activity by affecting IKKbeta kinase function. Specific serine mutations in FIP-3 reveal key sites for regulating IKKbeta phosphorylation and IkappaBalpha degradation.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Immunology
Background:
- NF-kappaB signaling is crucial for immune responses and cellular processes.
- FIP-3 (NEMO/IKKgamma) is a key regulator of NF-kappaB activity, interacting with IKK complex components.
- FIP-3 influences IkappaBalpha phosphorylation, ubiquitination, and degradation, but lacks intrinsic kinase activity.
Purpose of the Study:
- To investigate the role of specific serine residues in FIP-3 (NEMO/IKKgamma) function.
- To identify the kinase responsible for FIP-3 posttranslational modification.
- To elucidate how FIP-3 serine mutations impact IKKbeta kinase activity and downstream signaling.
Main Methods:
- Site-directed mutagenesis of FIP-3 (NEMO/IKKgamma) at five serine residues to alanine.
- Functional assays to assess IKKbeta kinase activity and IkappaBalpha phosphorylation.
- Identification of the responsible kinase using in vitro assays.
Main Results:
- Two serine-to-alanine mutations in FIP-3 significantly altered IKKbeta phosphorylation and kinase activity.
- Protein kinase Calpha was identified as the kinase responsible for FIP-3 posttranslational modification.
- Mutation of serine 141 (leucine zipper region) and serine 85 (IKKbeta interaction site) differentially affected FIP-3 function.
- Simultaneous mutation of both serines led to profound effects on IKKbeta and IkappaBalpha phosphorylation.
Conclusions:
- Specific serine residues in FIP-3 (NEMO/IKKgamma) are critical for regulating IKKbeta kinase activity.
- Protein kinase Calpha-mediated phosphorylation of FIP-3 is essential for proper NF-kappaB pathway modulation.
- Understanding these regulatory mechanisms provides insights into immune signaling and potential therapeutic targets.